Objective: To study the efficacy and safety of Reduning adjunctive Azithromycin Sequential therapy in the treatment of children mycoplasma pneumonia. Method: From 2008 January to 2013 January treated 80 cases of children with mycoplasma pneumonia from the hospital were as the object of study

all patients were diagnosed clinically

according to the different treatment methods all patients were divided into the control group treated with azithromycin and tobservation group treated with combined use of Reduning and azithromycin 40 cases each group.The differences in two groups were compared. Result: In observation group after treatment antifebrile

the time (1.73±1.03) d

cough time(3.44±1.44) d

length of hospital stay (6.12±2.12) d were significantly lower than tthose in he control group;the total efficiency was significantly higher than that. in the control group (P<0.05); in observation group after treatment the complications was less than that in the control group (P<0.05). Conclusion: Reduning adjunctive Azithromycin sequential therapy can effectively improve the children patients with mycoplasma pneumonia curative effect and safety